KaNDy Therapeutics snags Series C funding
UK-based KaNDy Therapeutics, a clinical-stage women’s health company, has raised 25 million pounds in Series C financing. The investors were Longitude Capital, Advent Life Sciences, Fountain Healthcare Partners, Forbion Capital Partners and OrbiMed.
29 August 2018•1 min read
